Key Stats for Synopsys Stock
- Current Price: $525.92
- Target Price (Mid): ~$933
- Street Target: ~$545
- Potential Total Return: ~77%
- Annualized IRR: ~14% / year
- Earnings Reaction: −1.52% after hours (May 27, 2026)
- Max Drawdown: −41.04% on 3/27/26
Now Live: Discover how much upside your favorite stocks could have using TIKR’s new Valuation Model (It’s free) >>>
What Happened?
Synopsys (SNPS) beat estimates on every major metric, raised its full-year outlook, and announced a cooperation agreement with activist investor Elliott Management all on the same afternoon. The stock still slipped roughly 1.5% after hours.
That gap between the news and the reaction is worth understanding. The market isn’t confused about what Synopsys delivered. It’s asking whether this earnings beat and Elliott’s formal board entry mark the start of a real monetization phase or simply confirm the business is executing inside a box that isn’t getting bigger.
President and CEO Sassine Ghazi addressed this on the call: “The expansion of AI positions Synopsys for sustainable growth and margin expansion. As AI scales both chip complexity and system-level design requirements, our leadership portfolio of engineering solutions across EDA, IP, and multiphysics simulation enables us to deliver differentiated value to customers and to capture a larger share of this expanding opportunity.”
The September 30, 2026, Investor Day is where he has committed to putting numbers behind that framing.
What the Quarter Actually Showed
Q2 revenue came in at $2.276 billion, above prior guidance. Non-GAAP operating margin hit 39.5%, non-GAAP EPS of $3.35 beat the analyst consensus of $3.15, and backlog ended at $11 billion.
CFO Shelagh Glaser flagged that $12.5 million of the revenue beat was an accounting reclassification of ANSYS channel revenue now recognized on a gross basis, but confirmed it was entirely neutral to EPS and cash flow. The underlying beat was operational.
Design Automation, which includes EDA software and ANSYS, generated approximately $1.822 billion in segment revenue. Within that, EDA grew slightly over 8% year-over-year, led by hardware-assisted verification (HAV), the tools that run chips against real software environments before fabrication, demand that grows directly with AI chip complexity. Design IP came in at $454 million, down approximately 6% year-over-year but up 12% sequentially from Q1, the first real signal that the IP trough management called in Q1 is holding.
Synopsys raised its full-year revenue target to $9.665 billion at the midpoint and lifted non-GAAP EPS guidance to $14.76, a $0.34 increase at the midpoint. Full-year free cash flow guidance was raised to approximately $2 billion, $100 million above prior guidance. Full-year non-GAAP operating margin now stands at 41% at the midpoint, more than 300 basis points above where the company finished fiscal 2025, per Ghazi on the call.
See historical and forward estimates for Synopsys stock (It’s free!) >>>
Three Things Happening at Once
Three developments converged this quarter, each meaningful on its own.
The first is clean execution beats and raised guidance across every line. The second is ANSYS integration progress: Glaser confirmed Synopsys expects to be roughly halfway through its committed cost synergy target by fiscal year-end, ahead of the original schedule.
The third is Elliott. Synopsys appointed Jesse Cohn to its board as an independent director, effective June 1, 2026. Cohn is a Managing Partner at Elliott with a track record as an investor in and director of public technology companies. On the call, Ghazi described full alignment with Elliott on two fronts: faster monetization of Synopsys’ value and improved operating efficiency. He wasn’t defensive about either point; he said Synopsys sees the same opportunity and that the inflection points are already visible in the business.
The IP Recovery and the Agentic Opportunity
Two signals from the call deserve more attention than the headline numbers.
On IP, Ghazi described a new model for hyperscaler customers building custom AI silicon through COT engagements (chip-on-tape, meaning custom chip designs taken all the way to fabrication). Instead of flat use fees, Synopsys is structuring agreements that capture a larger share of economics as those chips go into production. A small number of these new-model agreements are expected to be signed by the fiscal year-end.
On EDA, 20 customers are currently evaluating Synopsys’ agentic EDA solutions across more than 25 specialized AI agents covering design, verification, and analog flows. The model being explored pairs traditional subscription fees for human engineers with usage-based fees for AI agents. If that model takes hold, EDA revenue grows without requiring customers to add headcount, a meaningful structural shift.
Neither shift is in the current consensus. TIKR’s estimates table projects a revenue CAGR of approximately 14% through fiscal 2030. The IP new business model and agentic consumption pricing sit on top of that baseline. The $400 million revenue synergy target from multiphysics fusion, confirmed by Ghazi on the call, is also not yet in those numbers; it begins in fiscal 2027.
On valuation multiples, Synopsys trades at 25.09x NTM EV/EBITDA per TIKR. Cadence Design Systems (CDNS), its closest EDA peer, trades at 34.46x. Dassault Systèmes (DSY), the other major simulation software player, trades at 10.23x. Synopsys sits between the two, reflecting an integration discount that should compress as synergy delivery becomes visible in results.
See how Synopsys performs against its peers in TIKR (It’s free!) >>>
TIKR Advanced Model Analysis
- Current Price: $525.92
- Target Price (Mid): ~$933
- Potential Total Return: ~77%
- Annualized IRR: ~14% / year
See analysts’ growth forecasts and price targets for Synopsys stock (It’s free!) >>>
The TIKR mid-case model projects Synopsys reaching approximately $933 per share by 10/31/30, based on a mid-case revenue CAGR of approximately 11%. The two revenue drivers are continued AI-driven demand for EDA and HAV tools, and ANSYS scaling as multiphysics fusion reaches commercial availability. The margin driver is cost synergy realization, with net income margins expanding toward approximately 33% in the mid case.
The primary risk is IP underperformance. If the new hyperscaler engagement model takes longer to scale, results could track toward the low case of approximately $812, which still implies roughly 54% total return from current prices. The high case of approximately $1,366 requires agentic EDA consumption pricing to take hold within the forecast window.
On the Street, 15 Buys, 2 Outperforms, 7 Holds, 1 Underperform, and 1 No Opinion across 26 analysts per TIKR put the mean price target at approximately $545, about 4% above the current price. The TIKR mid-case implies roughly 77% upside, a significant divergence that reflects how much of the monetization story is still unpriced.
Conclusion
September 30, 2026, is the date that matters. That is when Ghazi committed to presenting the IP’s new business models, the agentic EDA pricing structure, and the long-term margin roadmap Elliott has been pushing for.
Before then, watch IP in Q3 (quarter ending July 31, 2026). Management guided for continued sequential improvement. Another 10%-plus sequential gain confirms the trough-is-in story and makes September a real catalyst. A flat or declining result puts the recovery narrative under pressure.
The Q2 beat is clean. The guidance is higher. Elliott is formally at the table. The next move belongs to September.
See what stocks billionaire investors are buying so you can follow the smart money with TIKR.
Should You Invest in Synopsys?
The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.
Pull up Synopsys, and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.
You can build a free watchlist to track Synopsys alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.
Analyze Synopsys on TIKR Free →
Looking for New Opportunities?
- See what stocks billionaire investors are buying so you can follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!
